CD8A and neoplasm: Similarly, in a murine model of non–small lung cancer, the combination of HDACi with HMA showed comparable effects, linking enhanced tumor-immune signaling with downregulation of the oncogene CMYC and its target genes, reversing immune exhaustion in CD8+ T cells (14).